Accessibility
The European Medicines Agency (EMA) is committed to ensuring accessibility of its website to all people, including those with cognitive or physical impairments.
Corporate
Updated on 1 October 2025:
'Accessibility compliance status' section to reflect accessibility improvements implemented in the 1 October website upgrade and upcoming upgrades
This website follows the Web Content Accessibility Guidelines (WCAG) 2.2, AA level.
On this website, you should be able to:
EMA will keep on improving the accessibility of this website and will update this page regularly to reflect improvements made.
This website is partially compliant with WCAG 2.2, AA level.
Despite our best efforts to ensure the accessibility of this website, we are aware of some limitations, which we are working to fix. Below is a description of known limitations. Please contact us if you encounter an issue not listed below:
We are actively addressing these issues through ongoing monthly improvements. You can track improvements made on our Website outages and upgrades page.
This website is tested and works with the latest versions of web browsers and the following most used assistive technologies:
We welcome your feedback on the accessibility of the this website and invite you to let us know if you encounter any accessibility barriers. You can contact us via:
You can also provide your feedback by using the ‘Help us improve our website’ section at the bottom of each page on this website and completing the brief form. Please do not include any personal data, such as your name, contact details, any information related to your health, or any other sensitive topic.